Ted Myles

(Mr. Edward Myles CPA)

Hält derzeit eine Position bei AMAG Pharmaceuticals Inc

Position

Position Company Period
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer AMAG Pharmaceuticals Inc 9. Januar 2020 -
Independent Director Scholar Rock Holding Corp 19. November 2018 - 29. Mai 2020
Chief Financial Officer, Executive Vice President, Treasurer AMAG Pharmaceuticals Inc 31. Dezember 2017 - 9. Januar 2020
Chief Financial Officer, Senior Vice President - Finance, Treasurer AMAG Pharmaceuticals Inc 11. April 2016 - 31. Dezember 2017
Chief Financial Officer, Chief Operating Officer Ocata Therapeutics Inc 21. Juli 2014 - 10. Februar 2016
Interim President, Chief Financial Officer, Executive Vice President - Corporate Development Ocata Therapeutics Inc 22. Januar 2014 - 21. Juli 2014
Chief Financial Officer, Executive Vice President - Corporate Development Ocata Therapeutics Inc 12. Juni 2013 - 22. Januar 2014
Ted Myles's trades of Scholar Rock Holding Corp's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Kauf • Verkauf • Geplanter Kauf • Geplanter Verkauf Netto-Kauf Netto-Verkauf Earnings
Abkürzungen K: Kauf, V: Verkauf, GK: Geplanter Kauf, GV: Geplanter Verkauf, S: Sonstiges
Datum der Benachrichtigung Datum der Transaktion K/V Art der Transaktion Anz. der Aktien
Kurs
Wert 		Anzahl der Aktien Kurs Wert Details
2025-03-12 2025-03-10
GV Geplanter Verkauf
29.395 -20.9%
34,87
1.025.004 USD 		29.395 -20.9% 34,87 1.025.004 USD
2025-03-12 2025-03-10
GV Geplanter Verkauf
112.897 -44.5%
35,82
4.043.971 USD 		112.897 -44.5% 35,82 4.043.971 USD
2025-02-20 2025-02-18
V Verkauf
7.809 -5.3%
36,83
287.598 USD 		7.809 -5.3% 36,83 287.598 USD
2025-01-21 2025-01-16
V Verkauf
12.539 -7.8%
44,20
554.189 USD 		12.539 -7.8% 44,20 554.189 USD
2024-10-10 2024-10-08
GV Geplanter Verkauf
37.187 -18.8%
34,90
1.297.659 USD 		37.187 -18.8% 34,90 1.297.659 USD
2024-10-07 2024-10-07
GV Geplanter Verkauf
31.250 -16.2%
29,05
907.813 USD 		31.250 -16.2% 29,05 907.813 USD
2024-10-07 2024-10-07
GV Geplanter Verkauf
25.812 -11.8%
27,27
703.893 USD 		25.812 -11.8% 27,27 703.893 USD
2024-10-07 2024-10-07
GV Geplanter Verkauf
37.206 -14.6%
26,83
998.237 USD 		37.206 -14.6% 26,83 998.237 USD
2024-10-07 2024-10-07
GV Geplanter Verkauf
111.972 -30.5%
25,61
2.867.603 USD 		111.972 -30.5% 25,61 2.867.603 USD
2024-06-18 2024-06-17
V Verkauf
9.458 -4.5%
8,98
84.978 USD 		9.458 -4.5% 8,98 84.978 USD
2024-02-21 2024-02-16
V Verkauf
4.744 -2.2%
15,74
74.686 USD 		4.744 -2.2% 15,74 74.686 USD
2024-01-18 2024-01-16
V Verkauf
6.634 -3.9%
15,93
105.670 USD 		6.634 -3.9% 15,93 105.670 USD
2023-12-29 2023-12-29
GV Geplanter Verkauf
300 -0.2%
19,51
5.853 USD 		300 -0.2% 19,51 5.853 USD
2023-12-29 2023-12-29
GV Geplanter Verkauf
12.159 -6.7%
18,82
228.780 USD 		12.159 -6.7% 18,82 228.780 USD
2023-12-08 2023-12-07
GV Geplanter Verkauf
24.914 -12.9%
17,53
436.820 USD 		24.914 -12.9% 17,53 436.820 USD
2023-11-03 2023-11-02
GV Geplanter Verkauf
35.007 -17.2%
12,51
438.039 USD 		35.007 -17.2% 12,51 438.039 USD
2021-11-15 2021-11-15
GV Geplanter Verkauf
4.879 -16.8%
35,05
171.006 USD 		4.879 -16.8% 35,05 171.006 USD
2021-11-15 2021-11-12
GV Geplanter Verkauf
49.848 -67.4%
35,12
1.750.437 USD 		49.848 -67.4% 35,12 1.750.437 USD
2021-11-15 2021-11-11
GV Geplanter Verkauf
23.574 -49.4%
35,20
829.857 USD 		23.574 -49.4% 35,20 829.857 USD
// ... existing code ... // ... rest of the file ...